Kairos Pharma, Ltd. (AMEX: KAPA) last traded at $0.743, down 10.34% on the session. The quote above updates while this page is open; the figures below are drawn from Kairos Pharma, Ltd.’s own filings and are restated only when a new one is published.
Kairos Pharma, Ltd. trades on AMEX under the ticker KAPA. Its market capitalisation is $17.61 million.
Valuation measures for Kairos Pharma, Ltd., derived from the latest quote and its most recent SEC filing.
| Market cap | $17.61M |
|---|---|
| Enterprise value | $15.25M |
| Price / book | 4.20 |
| Beta | 1.70 |
Trailing-twelve-month figures tagged in Kairos Pharma, Ltd.'s XBRL filings with the SEC.
| Net income (TTM) | -$5.80M |
|---|
| EPS (TTM) | -$0.280 |
|---|
| Return on equity | -138.51% |
|---|
| Cash | $2.63M |
|---|
Range and volume for KAPA over the past 52 weeks.
| 52-week high | $8.96 |
|---|---|
| 52-week low | $0.711 |
| Volume | 285.5K |
| Average volume | 614.3K |
| Previous close | $0.829 |
Invest a chosen dollar amount in Kairos Pharma, Ltd. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell KAPA.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.